184 related articles for article (PubMed ID: 19568366)
1. Application of intravitreal bevacizumab for circumscribed choroidal hemangioma.
Sagong M; Lee J; Chang W
Korean J Ophthalmol; 2009 Jun; 23(2):127-31. PubMed ID: 19568366
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma.
Mandal S; Naithani P; Venkatesh P; Garg S
Indian J Ophthalmol; 2011; 59(3):248-51. PubMed ID: 21586854
[TBL] [Abstract][Full Text] [Related]
3. Treatment of serous macular detachment associated with circumscribed choroidal hemangioma.
Kwon HJ; Kim M; Lee CS; Lee SC
Am J Ophthalmol; 2012 Jul; 154(1):137-145.e1. PubMed ID: 22465363
[TBL] [Abstract][Full Text] [Related]
4. PHOTODYNAMIC THERAPY WITH VERTEPORFIN PLUS INTRAVITREAL BEVACIZUMAB FOR CIRCUMSCRIBED CHOROIDAL HEMANGIOMA: 4 YEARS OF FOLLOW-UP.
Lasave AF; Serrano MA; Arevalo JF
Retin Cases Brief Rep; 2020; 14(2):110-115. PubMed ID: 29176523
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy for choroidal hemangioma unresponsive to ranibizumab.
Chan LW; Hsieh YT
Optom Vis Sci; 2014 Sep; 91(9):e226-9. PubMed ID: 25036544
[TBL] [Abstract][Full Text] [Related]
6. Polypoidal choroidal vasculopathy following photodynamic therapy for choroidal hemangioma.
Tuncer S; Demirci H; Shields CL; Shields JA
Eur J Ophthalmol; 2009; 19(1):159-62. PubMed ID: 19123168
[TBL] [Abstract][Full Text] [Related]
7. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
[TBL] [Abstract][Full Text] [Related]
8. Combination photodynamic therapy and intravitreal bevacizumab used to treat circumscribed choroidal hemangioma.
Hsu CC; Yang CS; Peng CH; Lee FL; Lee SM
J Chin Med Assoc; 2011 Oct; 74(10):473-7. PubMed ID: 22036141
[TBL] [Abstract][Full Text] [Related]
9. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma.
Boixadera A; García-Arumí J; Martínez-Castillo V; Encinas JL; Elizalde J; Blanco-Mateos G; Caminal J; Capeans C; Armada F; Navea A; Olea JL
Ophthalmology; 2009 Jan; 116(1):100-105.e1. PubMed ID: 18973950
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.
Song JH; Bae JH; Rho MI; Lee SC
Retina; 2010 Jun; 30(6):945-51. PubMed ID: 20531145
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic Therapy for Circumscribed Choroidal Hemangioma in 79 Consecutive Patients: Comparative Analysis of Factors Predictive of Visual Outcome.
Di Nicola M; Williams BK; Srinivasan A; Al-Dahmash S; Mashayekhi A; Shields JA; Shields CL
Ophthalmol Retina; 2020 Oct; 4(10):1024-1033. PubMed ID: 32344158
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.
Parodi MB; Iacono P; Kontadakis DS; Zucchiatti I; Cascavilla ML; Bandello F
Arch Ophthalmol; 2010 Sep; 128(9):1100-3. PubMed ID: 20837791
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography for evaluation of photodynamic therapy in symptomatic circumscribed choroidal hemangioma.
Liu W; Zhang Y; Xu G; Qian J; Jiang C; Li L
Retina; 2011 Feb; 31(2):336-43. PubMed ID: 21102373
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
17. Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation.
Lo Giudice G; Gismondi M; De Belvis V; Cian R; Tavolato M; Galan A
Retina; 2009; 29(7):949-55. PubMed ID: 19584653
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.
Lai TY; Chan WM; Liu DT; Luk FO; Lam DS
Br J Ophthalmol; 2008 May; 92(5):661-6. PubMed ID: 18356265
[TBL] [Abstract][Full Text] [Related]
19. Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.
Lazic R; Gabric N
Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):68-73. PubMed ID: 17111146
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes.
Blasi MA; Tiberti AC; Scupola A; Balestrazzi A; Colangelo E; Valente P; Balestrazzi E
Ophthalmology; 2010 Aug; 117(8):1630-7. PubMed ID: 20417564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
